|
|
|
|
|
by kobieyc
1800 days ago
|
|
Honestly I was surprised not to see any mention of IVM in the original post. Many of the points in the original article apply to what's going on with systemic reviews of IVM - see for example allegations of misconduct/fraud by theguardian to Elgazzar's big IVM study https://www.theguardian.com/science/2021/jul/16/huge-study-s... It does also bring into question the validity of Tess Lowrie's systematic review of ivermectin efficacy. Also, your systematic review [1] includes the Elgazzar as "low risk" of bias... when in fact Elgazzar had GLARING errors. It also makes me question the competence of everyone involved in this systematic review that they can't find these glaring errors but some random med student can. |
|
https://mobile.twitter.com/BretWeinstein/status/141654059008...
(Spoiler: not much.)